![PDF) Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France PDF) Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France](https://i1.rgstatic.net/publication/327629448_Health_Care_Resource_Utilization_and_Costs_among_Adult_Patients_with_Advanced_Soft_Tissue_Sarcoma_A_Retrospective_Medical_Record_Review_in_the_United_Kingdom_Spain_Germany_and_France/links/5b9a64c545851574f7c3bfe3/largepreview.png)
PDF) Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France
![Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System | Health Affairs Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System | Health Affairs](https://www.healthaffairs.org/cms/10.1377/hlthaff.2021.00070/asset/images/medium/figureex3.gif)
Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System | Health Affairs
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
![PDF) Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: Results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study) PDF) Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: Results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)](https://i1.rgstatic.net/publication/325047908_Cost-effectiveness_of_lung_volume_reduction_coil_treatment_in_patients_with_severe_emphysema_Results_from_the_2-year_follow-up_crossover_REVOLENS_study_REVOLENS-2_study/links/5af9454b0f7e9b026bf6de6d/largepreview.png)
PDF) Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: Results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
![THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2021/07/TAB-3-COSTA.gif)
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
![Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012 Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012](https://journals.sagepub.com/cms/10.1177/1352458512441566a/asset/images/large/10.1177_1352458512441566-fig4.jpeg)
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012
Supplementary materials Methods Calculation of costs and HCRU A cost of €24.13, which included official tariffs and surcharges
![Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study - Clinical Gastroenterology and Hepatology Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study - Clinical Gastroenterology and Hepatology](https://www.cghjournal.org/cms/asset/bb722360-df4b-4e65-be31-7e16eed4a451/gr1.jpg)
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre Study - Clinical Gastroenterology and Hepatology
![Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer](https://www.mdpi.com/vaccines/vaccines-08-00730/article_deploy/html/images/vaccines-08-00730-g004.png)
Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France | PLOS ONE
![THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2021/07/TAB-1-COSTA.gif)
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
Association des POIC - La base AMELI a enfin été mise à jour concernant la retrocession de la Trimebutine injectable. Aucune pharmacie centrale ne peut, désormais, refuser de la délivrer (sur prescription
![Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer](https://www.mdpi.com/vaccines/vaccines-08-00730/article_deploy/html/images/vaccines-08-00730-g001.png)
Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France | PLOS ONE
![Prix des médicaments - Comparaison avec l'étranger 2011, Conférence de presse santésuisse, interpharma et vips 20 Prix des médicaments - Comparaison avec l'étranger 2011, Conférence de presse santésuisse, interpharma et vips 20](https://image.slidesharecdn.com/mk2012-01-20apv2011allesaspraesentationenf-120120034435-phpapp01/85/prix-des-mdicaments-comparaison-avec-ltranger-2011-confrence-de-presse-santsuisse-interpharma-et-vips-20-janvier-2012-1-320.jpg?cb=1670483184)
Prix des médicaments - Comparaison avec l'étranger 2011, Conférence de presse santésuisse, interpharma et vips 20
![La libre fixation des prix des médicaments financés dans les groupes homogènes de séjour hospitalier : une exception au régime des prix administrés des médicaments à conserver ? | Cairn.info La libre fixation des prix des médicaments financés dans les groupes homogènes de séjour hospitalier : une exception au régime des prix administrés des médicaments à conserver ? | Cairn.info](https://www.cairn.info/vign_rev/JGES/JGES_202.jpg)
La libre fixation des prix des médicaments financés dans les groupes homogènes de séjour hospitalier : une exception au régime des prix administrés des médicaments à conserver ? | Cairn.info
![Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012 Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012](https://journals.sagepub.com/cms/10.1177/1352458512441566a/asset/images/large/10.1177_1352458512441566-fig5.jpeg)